![](https://webarchive.library.unt.edu/eot2008/20090118162952im_/http://www.fda.gov/graphics/dot_clear.gif) |
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Antiviral Drugs Advisory Committee
October 19-20, 2006
Janet Anderson, M.D.
• 18 U.S.C. 208 waiver (pdf)
Raymond Chung, M.D.
• 18 U.S.C. 208 waiver (pdf)
Douglas Fish, M.D.
• 18 U.S.C. 208 waiver (pdf)
Richard Haubrich, M.D.
• 18 U.S.C. 208 waiver (pdf)
Karen Murray, M.D.
• 18 U.S.C. 208 waiver (pdf)
Kenneth Sherman, M.D., Ph.D.
• 18 U.S.C. 208 waiver (pdf)
John Vierling, M.D.
• 18 U.S.C. 208 waiver (pdf)
Page updated:
September 29, 2006
|
![](https://webarchive.library.unt.edu/eot2008/20090118162952im_/http://www.fda.gov/graphics/dot_clear.gif) |